Search

Search Constraints

You searched for: Author/Creator Harris, Robert J.

Search Results

1. Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials. Issue 1 (31st August 2016)

2. Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action. Issue 3 (23rd February 2021)

5. Immune mediator expression signatures are associated with improved outcome in ovarian carcinoma. (3rd June 2019)

6. Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry. Issue 3 (4th December 2013)